Improving smoking cessation success through sleep and chess training
Official title: Increasing the Smoking Cessation Success Rate by Enhancing Improvement of Self-control Through Sleep-amplified Memory Consolidation
Run by Central Institute of Mental Health, Mannheim · NCT05726045 · Data updated 2026-11-12
This study is testing whether combining chess training and better sleep can help people quit smoking more successfully.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 140 (estimated) |
| Sponsor | Central Institute of Mental Health, Mannheim Academic / other |
| Locations | 1 site (Mannheim, Baden-Wurttemberg) |
| Status | Recruiting |
| Started | April 1, 2024 |
| Main results expected | June 30, 2026 |
| Study ends | June 30, 2026 |
| Registry record updated | January 31, 2025 |
| Trial ID | NCT05726045 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals diagnosed with severe tobacco use disorder who are right-handed and can communicate effectively with researchers.
✕Probably not a fit
Patients with severe internal, neurological, or psychiatric comorbidities, or those who have a history of brain injury, may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This project aims to enhance the effectiveness of smoking cessation programs for individuals with tobacco use disorder by integrating cognitive remediation training using chess and improving sleep through high-intensity interval training. Participants will undergo fMRI measurements and sleep monitoring before being assigned to one of four experimental groups that combine these interventions. The study hypothesizes that both chess-based training and sleep enhancement will improve treatment outcomes, either individually or in combination. The approach is designed to be cost-effective and increase patient compliance by utilizing app-based training methods.
Why it matters
Potential benefit: If successful, this study could significantly improve smoking cessation rates among individuals with tobacco use disorder.
How similar studies have gone: Previous studies have shown promise in enhancing cognitive control through cognitive remediation, making this approach a potentially valuable advancement in smoking cessation treatment.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * severe tobacco use disorder (TUD) according to DSM-5 * sufficient ability to communicate with investigators and answer questions in both written and verbal format * ability to provide fully informed consent and to use self-rating scales * right-handedness * HIIT can be performed without the risk of side effect (medical sports check) Exclusion Criteria: * severe internal, neurological, and/or psychiatric comorbidities; other Axis I mental disorders other than TUD according to ICD-10 and DSM 5 (except for mild depression, i.e. F32.0, adjustment disorder and specific phobias) in the last 12 months * history of brain injury * severe physical diseases * common exclusion criteria for MRI (e.g. metal, claustrophobia) * positive drug screening (opioids, benzodiazepines, barbiturates, cocaine, amphetamines) * psychotropic medication within the last 14 days * pregnancy
Where it's running
-
Klinik für Abhängiges Verhalten, Zentralinstitut für Seelische Gesundheit
Mannheim, Baden-Wurttemberg, Germany Recruiting
Study contacts
- Principal investigator: Sabine Vollstädt-Klein, Prof. Dr. — Central Institute of Mental Health, Mannheim
- Study coordinator: Sabine Vollstädt-Klein, Prof. Dr.
- Email: s.vollstaedt-klein@zi-mannheim.de
- Phone: +49-621/1703
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Personalized brain-targeted TMS for smoking cessation
A personalized brain-guided Transcranial Magnetic Stimulation (TMS) approach is tested against a standard TMS method to see if it better changes reward brain activity and reduces cravings and smoking in adults with tobacco use disorder.
-
Multilevel program to increase LDCT lung cancer screening and help African American smokers quit
This program will try combining low-dose CT screening with culturally tailored smoking-cessation support to help African American smokers who are eligible for LDCT quit and get screened.
-
TUBSIS 2.0 — an online program to help adults reduce or quit smoking and vaping
This program tests whether a free, anonymous, 4-week web-based course using mindfulness, self-compassion, and behavior-change techniques helps German-, English-, and Turkish-speaking adults who smoke or vape reduce or quit tobacco.
-
Impact of Menthol vs. Non-Menthol Cigarettes on Abuse Liability
This study tests whether menthol cigarettes have different abuse potential than non-menthol cigarettes in menthol cigarette users, using a within-subject design across lab sessions and daily diaries.
-
Ear acupressure plus nicotine replacement to ease withdrawal in psychiatric inpatients
This study will test whether adding ear acupressure (ear seeds) to standard nicotine replacement therapy helps psychiatric inpatients who must stop smoking reduce withdrawal symptoms, cravings, and anxiety.
-
Facilitating Tobacco Treatment in Veterans with Serious Mental Illness
This project tests an external facilitation approach to help VA clinics prescribe smoking medications more often to Veterans with serious mental illness who smoke.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.